Secretion of nizatidine into human breast milk after single and multiple doses

Boyd D. Obermeyer, Richard F. Bergstrom, John Callaghan, Mary Pat Knadler, Alan Golichowski, Alan Rubin

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Disposition of the H,-receptor antagonist nizatidine was studied in serum, urine, and breast milk. Five lactating women and five nonlactating women participated; the disposition of nizatidine was studied in three of the lactating women. Single and multiple doses of 150 mg nizatidine were administered orally. The disposition of nizatidine (half-life, 1 1 2 hours; apparent serum clearance, 40 L/hr; renal clearance, 27 L/hr; and apparent volume of distribution, 1.4 L/kg) was similar in lactating and nonlactating women. These pharmacokinetic results were analogous to observations for men in other studies. Nizatidine breast milk concentrations were directly proportional to corresponding serum concentrations. On average, 96 μg nizatidine, less than 0.1% of the maternal dose, was secreted into milk during a 12-hour interval after either single or multiple doses.

Original languageEnglish
Pages (from-to)724-730
Number of pages7
JournalClinical Pharmacology and Therapeutics
Volume47
Issue number6
StatePublished - Jun 1990

Fingerprint

Nizatidine
Human Milk
Serum
Half-Life
Milk
Pharmacokinetics
Mothers
Urine
Kidney

ASJC Scopus subject areas

  • Pharmacology

Cite this

Obermeyer, B. D., Bergstrom, R. F., Callaghan, J., Knadler, M. P., Golichowski, A., & Rubin, A. (1990). Secretion of nizatidine into human breast milk after single and multiple doses. Clinical Pharmacology and Therapeutics, 47(6), 724-730.

Secretion of nizatidine into human breast milk after single and multiple doses. / Obermeyer, Boyd D.; Bergstrom, Richard F.; Callaghan, John; Knadler, Mary Pat; Golichowski, Alan; Rubin, Alan.

In: Clinical Pharmacology and Therapeutics, Vol. 47, No. 6, 06.1990, p. 724-730.

Research output: Contribution to journalArticle

Obermeyer, BD, Bergstrom, RF, Callaghan, J, Knadler, MP, Golichowski, A & Rubin, A 1990, 'Secretion of nizatidine into human breast milk after single and multiple doses', Clinical Pharmacology and Therapeutics, vol. 47, no. 6, pp. 724-730.
Obermeyer BD, Bergstrom RF, Callaghan J, Knadler MP, Golichowski A, Rubin A. Secretion of nizatidine into human breast milk after single and multiple doses. Clinical Pharmacology and Therapeutics. 1990 Jun;47(6):724-730.
Obermeyer, Boyd D. ; Bergstrom, Richard F. ; Callaghan, John ; Knadler, Mary Pat ; Golichowski, Alan ; Rubin, Alan. / Secretion of nizatidine into human breast milk after single and multiple doses. In: Clinical Pharmacology and Therapeutics. 1990 ; Vol. 47, No. 6. pp. 724-730.
@article{cb825a70233247c799fa503e1e84e7b2,
title = "Secretion of nizatidine into human breast milk after single and multiple doses",
abstract = "Disposition of the H,-receptor antagonist nizatidine was studied in serum, urine, and breast milk. Five lactating women and five nonlactating women participated; the disposition of nizatidine was studied in three of the lactating women. Single and multiple doses of 150 mg nizatidine were administered orally. The disposition of nizatidine (half-life, 1 1 2 hours; apparent serum clearance, 40 L/hr; renal clearance, 27 L/hr; and apparent volume of distribution, 1.4 L/kg) was similar in lactating and nonlactating women. These pharmacokinetic results were analogous to observations for men in other studies. Nizatidine breast milk concentrations were directly proportional to corresponding serum concentrations. On average, 96 μg nizatidine, less than 0.1{\%} of the maternal dose, was secreted into milk during a 12-hour interval after either single or multiple doses.",
author = "Obermeyer, {Boyd D.} and Bergstrom, {Richard F.} and John Callaghan and Knadler, {Mary Pat} and Alan Golichowski and Alan Rubin",
year = "1990",
month = "6",
language = "English",
volume = "47",
pages = "724--730",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Secretion of nizatidine into human breast milk after single and multiple doses

AU - Obermeyer, Boyd D.

AU - Bergstrom, Richard F.

AU - Callaghan, John

AU - Knadler, Mary Pat

AU - Golichowski, Alan

AU - Rubin, Alan

PY - 1990/6

Y1 - 1990/6

N2 - Disposition of the H,-receptor antagonist nizatidine was studied in serum, urine, and breast milk. Five lactating women and five nonlactating women participated; the disposition of nizatidine was studied in three of the lactating women. Single and multiple doses of 150 mg nizatidine were administered orally. The disposition of nizatidine (half-life, 1 1 2 hours; apparent serum clearance, 40 L/hr; renal clearance, 27 L/hr; and apparent volume of distribution, 1.4 L/kg) was similar in lactating and nonlactating women. These pharmacokinetic results were analogous to observations for men in other studies. Nizatidine breast milk concentrations were directly proportional to corresponding serum concentrations. On average, 96 μg nizatidine, less than 0.1% of the maternal dose, was secreted into milk during a 12-hour interval after either single or multiple doses.

AB - Disposition of the H,-receptor antagonist nizatidine was studied in serum, urine, and breast milk. Five lactating women and five nonlactating women participated; the disposition of nizatidine was studied in three of the lactating women. Single and multiple doses of 150 mg nizatidine were administered orally. The disposition of nizatidine (half-life, 1 1 2 hours; apparent serum clearance, 40 L/hr; renal clearance, 27 L/hr; and apparent volume of distribution, 1.4 L/kg) was similar in lactating and nonlactating women. These pharmacokinetic results were analogous to observations for men in other studies. Nizatidine breast milk concentrations were directly proportional to corresponding serum concentrations. On average, 96 μg nizatidine, less than 0.1% of the maternal dose, was secreted into milk during a 12-hour interval after either single or multiple doses.

UR - http://www.scopus.com/inward/record.url?scp=0025374793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025374793&partnerID=8YFLogxK

M3 - Article

VL - 47

SP - 724

EP - 730

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 6

ER -